Crescendo Bioscience crescendobio.com


Public list: Medical Devices (6123) Smart Money VCs (6328)

Crescendo Bioscience is a molecular diagnostics company focused in rheumatology and located in South San Francisco, CA. Crescendo Bioscience develops quantitative, objective, blood tests to provide rheumatologists with deeper clinical insights to help enable more effective management of patients with autoimmune and inflammatory diseases.

Crescendo Bioscience is a molecular diagnostics company focused in rheumatology and located in South San Francisco, CA. Crescendo Bioscience develops quantitative, objective, blood tests to provide rheumatologists with deeper clinical insights to hel...Show all

Company (Acquired)

Phone: 650-351-1354

Fax:

341 Oyster Point Blvd.

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Crescendo Bioscience $130.4M Feb 5, 2014
See all 51 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Crescendo Bioscience Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors

Magellan Biosciences

North Billerica, Massachusetts, United States
AcquiredMagellan Diagnostics is a medical device company. The company develops and manufactures point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing.Login to see details

Oxford Immunotec

Oxfordshire, United Kingdom
IPO / Went publicOxford Immunotec (NASDAQ:OXFD) is a global diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions. T-SPOT is their platform technology, designed to simply and accurately examine a patient's cellular immune response to infection; the first product to come from this platform is the T-SPOT.TB Test, which is used to test for tuberculosis infection. The company's second product line is a range of assays for tick-b...Show allLogin to see details
See all 51 competitors